{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T10:04:30Z","timestamp":1784541870701,"version":"3.55.0"},"reference-count":39,"publisher":"Spandidos Publications","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncol Lett"],"DOI":"10.3892\/ol.2026.15733","type":"journal-article","created":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T05:20:07Z","timestamp":1782710407000},"page":"1-10","source":"Crossref","is-referenced-by-count":0,"title":["ARID3A knockdown facilitates ferroptosis partly through modulation of the PTEN\/Akt pathway in breast cancer"],"prefix":"10.3892","volume":"32","author":[{"given":"Pengfei","family":"Shi","sequence":"first","affiliation":[{"name":"Department of Thyroid and Breast Surgery, The Central Hospital of Wuhan, Tongji Medical College of Huazhong University of Science and Technology, Wuhan, Hubei 430013, P.R.\u00a0China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Yi","sequence":"additional","affiliation":[{"name":"Institute of Biomedical Engineering, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430022, P.R.\u00a0China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maojie","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Thyroid and Breast Surgery, The Central Hospital of Wuhan, Tongji Medical College of Huazhong University of Science and Technology, Wuhan, Hubei 430013, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongjun","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Thyroid and Breast Surgery, The Central Hospital of Wuhan, Tongji Medical College of Huazhong University of Science and Technology, Wuhan, Hubei 430013, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Thyroid and Breast Surgery, The Central Hospital of Wuhan, Tongji Medical College of Huazhong University of Science and Technology, Wuhan, Hubei 430013, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaming","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Thyroid and Breast Surgery, The Central Hospital of Wuhan, Tongji Medical College of Huazhong University of Science and Technology, Wuhan, Hubei 430013, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2026,6,29]]},"reference":[{"key":"key20260720122213_b1-ol-32-2-15733","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"key20260720122213_b2-ol-32-2-15733","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/s41392-024-02108-4","article-title":"Breast cancer: Pathogenesis and treatments","volume":"10","author":"Xiong","year":"2025","journal-title":"Signal Transduct Target Ther"},{"key":"key20260720122213_b3-ol-32-2-15733","doi-asserted-by":"publisher","first-page":"32","DOI":"10.21614\/chirurgia.3100","article-title":"Breast cancer: A heterogeneous pathology. Prognostic and predictive factors-a narrative review","volume":"120","author":"Popa","year":"2025","journal-title":"Chirurgia (Bucur)"},{"key":"key20260720122213_b4-ol-32-2-15733","doi-asserted-by":"publisher","first-page":"111457","DOI":"10.1016\/j.ejrad.2024.111457","article-title":"Artificial intelligence for breast cancer detection: Technology, challenges, and prospects","volume":"175","author":"D\u00edaz","year":"2024","journal-title":"Eur J Radiol"},{"key":"key20260720122213_b5-ol-32-2-15733","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.3390\/cancers17071102","article-title":"Molecular subtypes and mechanisms of breast cancer: Precision medicine approaches for targeted therapies","volume":"17","author":"Carvalho","year":"2025","journal-title":"Cancers (Basel)"},{"key":"key20260720122213_b6-ol-32-2-15733","doi-asserted-by":"publisher","first-page":"177561","DOI":"10.1016\/j.ejphar.2025.177561","article-title":"The role of ferroptosis in breast cancer: Tumor progression, immune microenvironment interactions and therapeutic interventions","volume":"996","author":"Wang","year":"2025","journal-title":"Eur J Pharmacol"},{"key":"key20260720122213_b7-ol-32-2-15733","doi-asserted-by":"publisher","first-page":"111869","DOI":"10.1016\/j.cellsig.2025.111869","article-title":"Role of ferroptosis in breast cancer: Molecular mechanisms and therapeutic interventions","volume":"134","author":"Wang","year":"2025","journal-title":"Cell Signal"},{"key":"key20260720122213_b8-ol-32-2-15733","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1080\/1061186X.2024.2399181","article-title":"Ferroptosis-targeting drugs in breast cancer","volume":"33","author":"Zhang","year":"2025","journal-title":"J Drug Target"},{"key":"key20260720122213_b9-ol-32-2-15733","doi-asserted-by":"publisher","first-page":"1499125","DOI":"10.3389\/fonc.2024.1499125","article-title":"Targeting ferroptosis: A promising strategy to overcome drug resistance in breast cancer","volume":"14","author":"Peng","year":"2024","journal-title":"Front Oncol"},{"key":"key20260720122213_b10-ol-32-2-15733","doi-asserted-by":"publisher","first-page":"2170","DOI":"10.1002\/prot.22718","article-title":"Solution NMR structure of the ARID domain of human AT-rich interactive domain-containing protein 3A: A human cancer protein interaction network target","volume":"78","author":"Liu","year":"2010","journal-title":"Proteins"},{"key":"key20260720122213_b11-ol-32-2-15733","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1093\/carcin\/bgaa118","article-title":"ARID3A promotes the development of colorectal cancer by upregulating AURKA","volume":"42","author":"Tang","year":"2021","journal-title":"Carcinogenesis"},{"key":"key20260720122213_b12-ol-32-2-15733","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1038\/s41419-022-05187-9","article-title":"Hepatic ARID3A facilitates liver cancer malignancy by cooperating with CEP131 to regulate an embryonic stem cell-like gene signature","volume":"13","author":"Shen","year":"2022","journal-title":"Cell Death Dis"},{"key":"key20260720122213_b13-ol-32-2-15733","doi-asserted-by":"publisher","first-page":"154948","DOI":"10.1016\/j.prp.2023.154948","article-title":"ARID3A and ARID3B exert direct regulatory control over the long non-coding RNAs (lncRNAs) MALAT1 and NORAD within the context of non-small cell lung cancer (NSCLC)","volume":"252","author":"Nasuh","year":"2023","journal-title":"Pathol Res Pract"},{"key":"key20260720122213_b14-ol-32-2-15733","doi-asserted-by":"publisher","first-page":"2040","DOI":"10.1038\/s41388-025-03376-2","article-title":"Phosphorylation enhanced OTUD3 deubiquitination ARID3A promotes the progress of cholangiocarcinoma","volume":"44","author":"Zhang","year":"2025","journal-title":"Oncogene"},{"key":"key20260720122213_b15-ol-32-2-15733","doi-asserted-by":"publisher","first-page":"e42024","DOI":"10.1016\/j.heliyon.2025.e42024","article-title":"Unveiling the prognostic value of ARID3A in breast cancer through bioinformatic analysis","volume":"11","author":"Cai","year":"2025","journal-title":"Heliyon"},{"key":"key20260720122213_b16-ol-32-2-15733","doi-asserted-by":"publisher","first-page":"641184","DOI":"10.3389\/fonc.2021.641184","article-title":"Identification and validation of the prognostic stemness biomarkers in bladder cancer bone metastasis","volume":"11","author":"Kang","year":"2021","journal-title":"Front Oncol"},{"key":"key20260720122213_b17-ol-32-2-15733","doi-asserted-by":"publisher","first-page":"103200","DOI":"10.1016\/j.redox.2024.103200","article-title":"ARID3A enhances chemoresistance of pancreatic cancer via inhibiting PTEN-induced ferroptosis","volume":"73","author":"Mao","year":"2024","journal-title":"Redox Biol"},{"key":"key20260720122213_b18-ol-32-2-15733","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1002\/jcp.31053","article-title":"The regulation of PTEN: Novel insights into functions as cancer biomarkers and therapeutic targets","volume":"238","author":"Liu","year":"2023","journal-title":"J Cell Physiol"},{"key":"key20260720122213_b19-ol-32-2-15733","doi-asserted-by":"publisher","first-page":"721","DOI":"10.3390\/molecules29030721","article-title":"The role of the PTEN tumor suppressor gene and its anti-angiogenic activity in melanoma and other cancers","volume":"29","author":"Maphutha","year":"2024","journal-title":"Molecules"},{"key":"key20260720122213_b20-ol-32-2-15733","doi-asserted-by":"publisher","first-page":"154902","DOI":"10.1016\/j.prp.2023.154902","article-title":"New emerging targets in osteosarcoma therapy: PTEN and PI3K\/Akt crosstalk in carcinogenesis","volume":"251","author":"Sadrkhanloo","year":"2023","journal-title":"Pathol Res Pract"},{"key":"key20260720122213_b21-ol-32-2-15733","doi-asserted-by":"publisher","first-page":"a036129","DOI":"10.1101\/cshperspect.a036129","article-title":"Discovery of the PTEN tumor suppressor and its connection to the PI3K and AKT oncogenes","volume":"10","author":"Parsons","year":"2020","journal-title":"Cold Spring Harb Perspect Med"},{"key":"key20260720122213_b22-ol-32-2-15733","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.trsl.2024.05.007","article-title":"GPX4 transcriptionally promotes liver cancer metastasis via GRHL3\/PTEN\/PI3K\/AKT axis","volume":"271","author":"Pan","year":"2024","journal-title":"Transl Res"},{"key":"key20260720122213_b23-ol-32-2-15733","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1007\/s12672-025-02330-8","article-title":"The m6A methyltransferase METTL3 affects ferroptosis in non-small cell lung cancer by regulating the PTEN\/PI3K\/AKT pathway","volume":"16","author":"Wu","year":"2025","journal-title":"Discov Oncol"},{"key":"key20260720122213_b24-ol-32-2-15733","doi-asserted-by":"publisher","first-page":"112536","DOI":"10.1016\/j.celrep.2023.112536","article-title":"AKT activation because of PTEN loss upregulates xCT via GSK3\u03b2\/NRF2, leading to inhibition of ferroptosis in PTEN-mutant tumor cells","volume":"42","author":"Cahuzac","year":"2023","journal-title":"Cell Rep"},{"key":"key20260720122213_b25-ol-32-2-15733","doi-asserted-by":"publisher","first-page":"1372330","DOI":"10.3389\/fcell.2024.1372330","article-title":"Regulation of ferroptosis by PI3K\/Akt signaling pathway: A promising therapeutic axis in cancer","volume":"12","author":"Su","year":"2024","journal-title":"Front Cell Dev Biol"},{"key":"key20260720122213_b26-ol-32-2-15733","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1007\/s10565-024-09963-5","article-title":"NMF typing and machine learning algorithm-based exploration of preeclampsia-related mechanisms on ferroptosis signature genes","volume":"41","author":"Liu","year":"2024","journal-title":"Cell Biol Toxicol"},{"key":"key20260720122213_b27-ol-32-2-15733","doi-asserted-by":"publisher","first-page":"1533033818764470","DOI":"10.1177\/1533033818764470","article-title":"High-Dose deferoxamine treatment disrupts intracellular iron homeostasis, reduces growth, and induces apoptosis in metastatic and nonmetastatic breast cancer cell lines","volume":"17","author":"Bajbouj","year":"2018","journal-title":"Technol Cancer Res Treat"},{"key":"key20260720122213_b28-ol-32-2-15733","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1038\/s41580-024-00703-5","article-title":"The cell biology of ferroptosis","volume":"25","author":"Dixon","year":"2024","journal-title":"Nat Rev Mol Cell Biol"},{"key":"key20260720122213_b29-ol-32-2-15733","doi-asserted-by":"publisher","first-page":"101987","DOI":"10.1016\/j.toxrep.2025.101987","article-title":"PTEN-mediated resistance in cancer: From foundation to future therapies","volume":"14","author":"Tufail","year":"2025","journal-title":"Toxicol Rep"},{"key":"key20260720122213_b30-ol-32-2-15733","doi-asserted-by":"publisher","first-page":"825484","DOI":"10.3389\/fonc.2022.825484","article-title":"Systemic deficiency of PTEN accelerates breast cancer growth and metastasis","volume":"12","author":"Chen","year":"2022","journal-title":"Front Oncol"},{"key":"key20260720122213_b31-ol-32-2-15733","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.21037\/tcr-23-826","article-title":"The effects of the tumor suppressor gene PTEN on the proliferation and apoptosis of breast cancer cells via AKT phosphorylation","volume":"12","author":"Zhang","year":"2023","journal-title":"Transl Cancer Res"},{"key":"key20260720122213_b32-ol-32-2-15733","doi-asserted-by":"publisher","first-page":"e684","DOI":"10.1002\/mco2.684","article-title":"Ubiquitin-specific protease 22 controls melanoma metastasis and vulnerability to ferroptosis through targeting SIRT1\/PTEN\/PI3K signaling","volume":"5","author":"Sun","year":"2024","journal-title":"MedComm (2020)"},{"key":"key20260720122213_b33-ol-32-2-15733","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.2174\/0113816128343266241230045019","article-title":"A review unveiling the ferroptosis-regulated cell signalling pathways in breast cancer to elucidate potent targets for cancer management","volume":"31","author":"Pandey","year":"2025","journal-title":"Curr Pharm Des"},{"key":"key20260720122213_b34-ol-32-2-15733","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1158\/0008-5472.CAN-08-3389","article-title":"Basal subtype and MAPK\/ERK kinase (MEK)-phosphoinositide 3-kinase feedback signaling determine susceptibility of breast cancer cells to MEK inhibition","volume":"69","author":"Mirzoeva","year":"2009","journal-title":"Cancer Res"},{"key":"key20260720122213_b35-ol-32-2-15733","doi-asserted-by":"publisher","first-page":"2570","DOI":"10.1002\/ijc.29923","article-title":"Constitutive activation of STAT3 in breast cancer cells: A review","volume":"138","author":"Banerjee","year":"2016","journal-title":"Int J Cancer"},{"key":"key20260720122213_b36-ol-32-2-15733","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1080\/01635581.2025.2521884","article-title":"PI3K\/AKT\/mTOR pathway in breast cancer pathogenesis and therapy: Insights into phytochemical-based therapeutics","volume":"77","author":"Wali","year":"2025","journal-title":"Nutr Cancer"},{"key":"key20260720122213_b37-ol-32-2-15733","doi-asserted-by":"publisher","first-page":"e3998","DOI":"10.1002\/cbf.3998","article-title":"The PI3K\/AKT\/mTOR signaling pathway in breast cancer: Review of clinical trials and latest advances","volume":"42","author":"Khorasani","year":"2024","journal-title":"Cell Biochem Funct"},{"key":"key20260720122213_b38-ol-32-2-15733","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1177\/10600280241241531","article-title":"Capivasertib: A Novel AKT inhibitor approved for hormone-receptor-positive, HER-2-Negative metastatic breast cancer","volume":"58","author":"Luboff","year":"2024","journal-title":"Ann Pharmacother"},{"key":"key20260720122213_b39-ol-32-2-15733","doi-asserted-by":"publisher","first-page":"2508","DOI":"10.3390\/cells11162508","article-title":"PI3K\/AKT\/mTOR-targeted therapy for breast cancer","volume":"11","author":"Zhu","year":"2022","journal-title":"Cells"}],"container-title":["Oncology Letters"],"original-title":[],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T09:22:18Z","timestamp":1784539338000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/ol.2026.15733"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,29]]},"references-count":39,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,6,29]]}},"URL":"https:\/\/doi.org\/10.3892\/ol.2026.15733","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,29]]}}}